Cyclin D1 Expression and the Inhibitory Effect of Celecoxib on Ovarian Tumor Growth in VivoReport as inadecuate




Cyclin D1 Expression and the Inhibitory Effect of Celecoxib on Ovarian Tumor Growth in Vivo - Download this document for free, or read online. Document in PDF available to download.

Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, 261 Huansha Road, Hangzhou, Zhejiang, 310006, China





*

Author to whom correspondence should be addressed.



Abstract The report aims to investigate the relationship between the expression of cyclin D1 and Cyclooxgenase-2 COX-2, thus to explore the molecular mechanisms of the antitumor efficacy of Celecoxib, a COX-2 inhibitor. Human ovarian SKOV-3 carcinoma cell xenograft-bearing mice were treated with Celecoxib by infusing gaster i.g. twice-day for 21 days. The mRNA levels of COX-2 and cyclin D1 were determined by RT-PCR. The expression of cyclin D1 at the protein level was detected by immunohistochemistry, while COX-2 protein expression was determined by Western blot. A high-dose of Celecoxib 100 mg-kg significantly inhibited tumor growth P 0.05, and the expression of cyclin D1 was reduced by 61%. Celecoxib decreased the proliferation cell index by 40% P 0.001 and increased apoptotic index by 52% P 0.05 in high-dose Celecoxib treated group. Our results suggest that the antitumor efficacy of Celecoxib against ovarian cancer in mice may in part be mediated through suppression of cyclin D1, which may contribute to its ability to suppress proliferation. View Full-Text

Keywords: Celecoxib; cyclin D1; ovarian cancer; proliferation; apoptosis Celecoxib; cyclin D1; ovarian cancer; proliferation; apoptosis





Author: Wei Li * , Hong-Ru Jiang, Xiao-Li Xu, Jie Wang, Jun Zhang, Mei-Lin Liu and Ling-Yun Zhai

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents